{"id":10432,"date":"2026-01-24T12:18:38","date_gmt":"2026-01-24T04:18:38","guid":{"rendered":"https:\/\/preciseaesthetics.hk\/?page_id=10432"},"modified":"2026-01-24T13:32:58","modified_gmt":"2026-01-24T05:32:58","slug":"mounjaro-tirzepatide","status":"publish","type":"page","link":"https:\/\/preciseaesthetics.hk\/en\/treatments\/mounjaro-tirzepatide\/","title":{"rendered":"Mounjaro (Tirzepatide)"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Mounjaro (Tirzepatide)<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\"Mounjaro<\/a><\/h3>

What is Mounjaro?<\/b><\/h3>
  • Mounjaro (active ingredient: Tirzepatide) is a once-weekly prescription medicine administered by subcutaneous injection, indicated for:<\/span>
    • Glycaemic control in adults with type 2 diabetes (can be used alone, or in combination with other antidiabetic medicines and\/or insulin)<\/span><\/li>
    • Chronic weight management (weight loss and maintenance), to be used together with a reduced-calorie diet and increased physical activity<\/span><\/li><\/ul><\/li>
    • An initial doctor\u2019s assessment is recommended (available doses: 2.5 mg, 5 mg, 7.5 mg, 10 mg) to tailor the treatment plan.<\/span><\/li><\/ul>

      How does Mounjaro work?<\/b><\/h3>
      • Dual receptor agonist of GLP-1 and GIP:<\/span>
        • GLP-1: slows gastric emptying, increases satiety, enhances glucose-dependent insulin secretion, and suppresses glucagon to help lower blood glucose and appetite.<\/span><\/li>
        • GIP: boosts insulin secretion after meals and acts on adipocytes to reduce fat storage.<\/span><\/li><\/ul><\/li>
        • Synergistic advantages:<\/span>
          • More comprehensive and stable blood glucose control with reduced post\u2011meal glucose fluctuations.<\/span><\/li>
          • Stronger appetite regulation and weight reduction; clinical data suggest superior weight\u2011loss outcomes versus traditional GLP\u20111\u2013only regimens.<\/span><\/li>
          • May lower certain cardiovascular risk factors.<\/span><\/li><\/ul><\/li><\/ul>

            What is Mounjaro best suited for?<\/b><\/h3>
            • Chronic weight management (adults):<\/span>
              • BMI \u2265 30 kg\/m\u00b2 (obesity), or<\/span><\/li>
              • BMI \u2265 27 kg\/m\u00b2 with weight\u2011related health conditions (e.g., prediabetes, type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease).<\/span><\/li><\/ul><\/li>
              • Type 2 diabetes (adults):<\/span>
                • When diet and exercise alone are insufficient.<\/span><\/li>
                • As monotherapy if metformin is not appropriate or not tolerated.<\/span><\/li>
                • May be combined with other oral antidiabetic agents or insulin.<\/span><\/li><\/ul><\/li><\/ul>

                  What to expect during treatment?<\/b><\/h3>
                  • Doctor consultation and assessment: medical history, current medications, BMI\/waist circumference, past weight\u2011loss attempts, retinal status (e.g., diabetic retinopathy), gastrointestinal symptoms, and any history of gallbladder or pancreatic disease.<\/span><\/li>
                  • Personalised plan: once\u2011weekly subcutaneous injections with gradual dose escalation, alongside diet and exercise guidance; if used with insulin or sulfonylureas, dosage adjustments may be needed to lower risk of hypoglycaemia.<\/span><\/li>
                  • Injection technique: demonstrated by clinical staff; inject into the abdomen, thigh, or outer upper arm; rotate injection sites each time; aim for the same day each week.<\/span><\/li>
                  • Monitoring and follow\u2011ups: review weight, waist circumference, glucose\/HbA1c, renal function, lipid profile, and tolerability; adjust dose according to response.<\/span><\/li><\/ul>

                    What are the treatment areas?<\/b><\/h3>
                    • This is a systemic therapy, not a local fat\u2011dissolving or device\u2011based treatment.<\/span><\/li>
                    • Injection sites are merely routes of administration (abdomen, thigh, outer upper arm) and are not intended for targeted spot fat reduction.<\/span><\/li><\/ul>

                      Is the treatment painful?<\/b><\/h3>
                      • Most people feel only brief, mild needle prick or transient warmth.<\/span><\/li>
                      • Possible local reactions include redness, itchiness, small bruises, or mild pain at the injection site, usually resolving within a few days; icing or rotating sites can help.<\/span><\/li><\/ul>

                        How many sessions are needed to see results?<\/b><\/h3>
                        • Varies by individual. Continuous once\u2011weekly use with stepwise dose escalation is typically needed to balance efficacy and tolerability.<\/span><\/li>
                        • The better the adherence to diet and exercise, the more favourable the weight and glucose outcomes tend to be.<\/span><\/li><\/ul>

                          How soon can I see results?<\/b><\/h3>
                          • Appetite reduction and increased satiety: often noticeable within the first few weeks.<\/span><\/li>
                          • Weight change: generally emerges gradually over several weeks to months; sustained treatment and lifestyle measures help consolidate results.<\/span><\/li>
                          • Glycaemic control: typically improves with continued therapy and appropriate dose adjustments.<\/span><\/li><\/ul>

                            What to avoid after the treatment?<\/b><\/h3>
                            • During initiation and dose escalation, avoid very fatty or large meals to reduce nausea or stomach discomfort.<\/span><\/li>
                            • If significant nausea, vomiting, or diarrhoea occurs, maintain hydration and electrolytes to prevent dehydration.<\/span><\/li>
                            • Inform your healthcare team before surgery or deep sedation that you are using a GLP\u20111\/GIP agent to plan fasting and any temporary interruption, reducing aspiration risk.<\/span><\/li>
                            • If combined with insulin or sulfonylureas, intensify glucose monitoring and adjust doses per medical advice.<\/span><\/li><\/ul>

                              Are there any side effects?<\/b><\/h3>
                              • Common: nausea, vomiting, diarrhoea, constipation, abdominal pain, heartburn\/reflux, reduced appetite, dizziness, fatigue, taste changes, injection\u2011site reactions; mild increase in heart rate; elevations in pancreatic enzymes (amylase\/lipase).<\/span><\/li>
                              • Hypoglycaemia: risk increases when used with insulin or sulfonylureas (less common when used alone or with metformin\/SGLT2 inhibitors).<\/span><\/li>
                              • Less common but important: gallstones and cholecystitis; delayed gastric emptying\/worsening gastroparesis symptoms; orthostatic hypotension or blood\u2011pressure\u2011related events; hair loss; allergic or hypersensitivity reactions (rarely angioedema\/anaphylaxis).<\/span><\/li>
                              • Acute pancreatitis (rare but serious): if you develop persistent, severe abdominal pain (possibly radiating to the back, with or without vomiting), stop the medication and seek immediate medical care; if confirmed, do not restart.<\/span><\/li>
                              • Ophthalmic: use with caution in patients with diabetic retinopathy; monitor for vision changes.<\/span><\/li>
                              • Drug interactions: delayed gastric emptying may affect absorption of oral medicines, especially at initiation or after each dose escalation; narrow therapeutic index drugs (e.g., warfarin, digoxin) may require closer monitoring; oral contraceptive effectiveness may be reduced\u2014consider non\u2011oral methods or add barrier protection for 4 weeks after starting or after each dose increase.<\/span><\/li>
                              • Pregnancy and breastfeeding: not recommended during pregnancy; if planning for pregnancy, discontinue at least 1 month before conception; discuss risks\/benefits if breastfeeding.<\/span><\/li><\/ul>

                                Friendly reminders<\/b><\/h3>
                                • Mounjaro is not a quick\u2011fix weight\u2011loss solution; suggest to pair with diet control and exercise, and attend scheduled follow\u2011ups.<\/span><\/li>
                                • Outcomes vary with individual physiology, concomitant medicines, lifestyle, and adherence; your doctor will adjust dosing and pacing based on your response and tolerability.<\/span><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

                                  Mounjaro (Tirzepatide) What is Mounjaro? Mounjaro (active ingredient: Tirzepatide) is a once-weekly prescription medicine administered by subcutaneous injection, indicated for: Glycaemic control in adults with type 2 diabetes (can be used alone, or in combination with other antidiabetic medicines and\/or insulin) Chronic weight management (weight loss and maintenance), to be used together with a reduced-calorie diet and increased physical activity An initial doctor\u2019s assessment is recommended (available doses: 2.5 mg, 5 mg, 7.5 mg, 10 mg) to tailor the treatment plan. How does Mounjaro work? Dual receptor agonist of GLP-1 and GIP: GLP-1: slows gastric emptying, increases satiety, enhances glucose-dependent insulin secretion, and suppresses glucagon to help lower blood glucose and appetite. GIP: boosts insulin secretion after meals and acts […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":1587,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"full-width-container","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"slim_seo":{"title":"Mounjaro (Tirzepatide) - Precise Medical Aesthetics","description":"Mounjaro (Tirzepatide) What is Mounjaro? Mounjaro (active ingredient: Tirzepatide) is a once-weekly prescription medicine administered by subcutaneous injection"},"footnotes":""},"class_list":["post-10432","page","type-page","status-publish","hentry"],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/preciseaesthetics.hk\/en\/wp-json\/wp\/v2\/pages\/10432","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/preciseaesthetics.hk\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/preciseaesthetics.hk\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/preciseaesthetics.hk\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/preciseaesthetics.hk\/en\/wp-json\/wp\/v2\/comments?post=10432"}],"version-history":[{"count":10,"href":"https:\/\/preciseaesthetics.hk\/en\/wp-json\/wp\/v2\/pages\/10432\/revisions"}],"predecessor-version":[{"id":10472,"href":"https:\/\/preciseaesthetics.hk\/en\/wp-json\/wp\/v2\/pages\/10432\/revisions\/10472"}],"up":[{"embeddable":true,"href":"https:\/\/preciseaesthetics.hk\/en\/wp-json\/wp\/v2\/pages\/1587"}],"wp:attachment":[{"href":"https:\/\/preciseaesthetics.hk\/en\/wp-json\/wp\/v2\/media?parent=10432"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}